JP Morgan Chase’s ADMA Biologics ADMA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $4.69M | Buy |
512,926
+213,845
| +72% | +$3.37M | ﹤0.01% | 3374 |
|
|
2025
Q4 | $5.46M | Sell |
299,081
-162,617
| -35% | -$2.74M | ﹤0.01% | 3225 |
|
|
2025
Q3 | $6.77M | Buy |
461,698
+33,395
| +8% | +$572K | ﹤0.01% | 3095 |
|
|
2025
Q2 | $7.8M | Sell |
428,303
-353,891
| -45% | -$7.22M | ﹤0.01% | 2766 |
|
|
2025
Q1 | $15.5M | Buy |
782,194
+14,929
| +2% | +$258K | ﹤0.01% | 2138 |
|
|
2024
Q4 | $13.2M | Buy |
767,265
+561,310
| +273% | +$10.6M | ﹤0.01% | 2437 |
|
|
2024
Q3 | $4.12M | Sell |
205,955
-33,633
| -14% | -$523K | ﹤0.01% | 3356 |
|
|
2024
Q2 | $2.68M | Buy |
239,588
+32,707
| +16% | +$274K | ﹤0.01% | 3535 |
|
|
2024
Q1 | $1.37M | Buy |
206,881
+20,513
| +11% | +$112K | ﹤0.01% | 4121 |
|
|
2023
Q4 | $842K | Sell |
186,368
-964
| -0.5% | -$3.57K | ﹤0.01% | 4451 |
|
|
2023
Q3 | $671K | Buy |
187,332
+11,898
| +7% | +$45.8K | ﹤0.01% | 4312 |
|
|
2023
Q2 | $647K | Buy |
175,434
+1,210
| +0.7% | +$4.49K | ﹤0.01% | 4338 |
|
|
2023
Q1 | $577K | Sell |
174,224
-110,684
| -39% | -$383K | ﹤0.01% | 4403 |
|
|
2022
Q4 | $1.1M | Buy |
284,908
+174,912
| +159% | +$540K | ﹤0.01% | 3969 |
|
|
2022
Q3 | $268K | Buy |
109,996
+1,902
| +2% | +$4.56K | ﹤0.01% | 4807 |
|
|
2022
Q2 | $214K | Buy |
108,094
+28,988
| +37% | +$57K | ﹤0.01% | 5046 |
|
|
2022
Q1 | $144K | Buy |
79,106
+61,909
| +360% | +$96.6K | ﹤0.01% | 5350 |
|
|
2021
Q4 | $24K | Buy |
+17,197
| New | +$22.6K | ﹤0.01% | 6168 |
|
|
2021
Q3 | – | Sell |
-84,099
| Closed | -$135K | – | 6445 |
|
|
2021
Q2 | $135K | Buy |
84,099
+33,643
| +67% | +$59.2K | ﹤0.01% | 5431 |
|
|
2021
Q1 | $88K | Buy |
50,456
+6,899
| +16% | +$15.8K | ﹤0.01% | 5402 |
|
|
2020
Q4 | $85K | Buy |
43,557
+21,120
| +94% | +$44.4K | ﹤0.01% | 5040 |
|
|
2020
Q3 | $49K | Buy |
22,437
+2,186
| +11% | +$5.99K | ﹤0.01% | 4936 |
|
|
2020
Q2 | $59K | Sell |
20,251
-2,385
| -11% | -$6.85K | ﹤0.01% | 4781 |
|
|
2020
Q1 | $65K | Buy |
22,636
+6,136
| +37% | +$21.2K | ﹤0.01% | 4650 |
|
|
2019
Q4 | $66K | Sell |
16,500
-148,029
| -90% | -$645K | ﹤0.01% | 5034 |
|
|
2019
Q3 | $732K | Buy |
164,529
+157,020
| +2,091% | +$656K | ﹤0.01% | 4004 |
|
|
2019
Q2 | $28K | Buy |
7,509
+1,259
| +20% | +$5.56K | ﹤0.01% | 5370 |
|
|
2019
Q1 | $24K | Sell |
6,250
-23,654
| -79% | -$83.6K | ﹤0.01% | 5354 |
|
|
2018
Q4 | $72K | Sell |
29,904
-199,095
| -87% | -$986K | ﹤0.01% | 4966 |
|
|
2018
Q3 | $1.42M | Buy |
228,999
+81,003
| +55% | +$466K | ﹤0.01% | 3694 |
|
|
2018
Q2 | $667K | Buy |
147,996
+108,505
| +275% | +$541K | ﹤0.01% | 4037 |
|
|
2018
Q1 | $182K | Buy |
+39,491
| New | +$157K | ﹤0.01% | 4401 |
|
Other funds holding ADMA
VCM
VPM
N
